LAURIA PINTER, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 18.391
NA - Nord America 15.219
AS - Asia 8.578
SA - Sud America 1.838
OC - Oceania 463
AF - Africa 191
Continente sconosciuto - Info sul continente non disponibili 28
AN - Antartide 1
Totale 44.709
Nazione #
US - Stati Uniti d'America 14.185
GB - Regno Unito 4.010
IT - Italia 3.819
DE - Germania 3.012
CN - Cina 3.007
JP - Giappone 1.438
SG - Singapore 1.292
FR - Francia 1.100
ES - Italia 1.074
BR - Brasile 983
IN - India 793
SE - Svezia 767
RU - Federazione Russa 736
IE - Irlanda 696
CA - Canada 554
NL - Olanda 513
AU - Australia 423
TR - Turchia 374
MX - Messico 354
CH - Svizzera 338
BE - Belgio 320
DK - Danimarca 311
ID - Indonesia 307
KR - Corea 307
AR - Argentina 282
CO - Colombia 267
AT - Austria 249
VN - Vietnam 242
FI - Finlandia 214
PL - Polonia 200
PT - Portogallo 188
CL - Cile 166
GR - Grecia 152
HK - Hong Kong 137
IL - Israele 134
UA - Ucraina 124
NO - Norvegia 116
RO - Romania 116
TW - Taiwan 110
HU - Ungheria 85
TH - Thailandia 81
PE - Perù 58
CR - Costa Rica 52
EU - Europa 45
MY - Malesia 44
ZA - Sudafrica 44
IR - Iran 43
EC - Ecuador 41
CZ - Repubblica Ceca 40
NZ - Nuova Zelanda 39
SA - Arabia Saudita 34
AE - Emirati Arabi Uniti 33
PH - Filippine 33
SI - Slovenia 32
LT - Lituania 30
TN - Tunisia 30
EG - Egitto 29
MA - Marocco 29
HR - Croazia 25
RS - Serbia 25
NP - Nepal 21
BG - Bulgaria 20
CY - Cipro 19
LB - Libano 19
PK - Pakistan 19
UY - Uruguay 19
IQ - Iraq 18
PA - Panama 15
SK - Slovacchia (Repubblica Slovacca) 15
BD - Bangladesh 14
KZ - Kazakistan 13
LU - Lussemburgo 12
LV - Lettonia 12
GT - Guatemala 11
EE - Estonia 9
JO - Giordania 9
NI - Nicaragua 9
RE - Reunion 9
KE - Kenya 8
PR - Porto Rico 8
SV - El Salvador 8
BO - Bolivia 7
QA - Qatar 7
SN - Senegal 7
UZ - Uzbekistan 7
CU - Cuba 6
DZ - Algeria 6
GH - Ghana 6
PY - Paraguay 6
SC - Seychelles 6
VE - Venezuela 6
HN - Honduras 5
LY - Libia 5
PS - Palestinian Territory 5
BA - Bosnia-Erzegovina 4
AD - Andorra 3
AL - Albania 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
Totale 44.667
Città #
Southend 2.845
Milan 869
Hanover 861
Fairfield 838
Singapore 753
Redwood City 708
Dublin 658
Wilmington 631
Seattle 585
Princeton 582
Chandler 537
Beijing 497
Ashburn 495
Houston 448
Woodbridge 440
Tokyo 396
New York 392
Frankfurt am Main 389
Council Bluffs 380
Cambridge 337
Rome 318
Nanjing 300
Ann Arbor 272
Madrid 224
Bengaluru 222
Jakarta 221
Dearborn 214
Des Moines 214
Paris 210
Shanghai 209
São Paulo 189
Berlin 169
Toronto 156
London 154
Chicago 149
Barcelona 143
Santa Clara 141
Vienna 121
Santiago 120
Buenos Aires 113
Sydney 113
Duncan 108
Changsha 104
Istanbul 103
Nanchang 101
Guangzhou 100
San Diego 99
Bogotá 97
Jinan 95
Nuremberg 94
Shenyang 89
Zurich 89
Boston 86
Ho Chi Minh City 85
Athens 83
Medellín 83
Würzburg 82
Munich 80
Brussels 79
Amsterdam 78
Los Angeles 78
Phoenix 78
Hangzhou 77
Seoul 75
Helsinki 74
Bologna 72
Maastricht 68
Mumbai 67
Taipei 66
Verona 65
Tianjin 64
Naples 61
Hebei 60
Philadelphia 60
Ottawa 58
Rio de Janeiro 58
Florence 57
Oslo 57
Silver Spring 57
Zhengzhou 56
Warsaw 55
Brooklyn 53
Valencia 53
Melbourne 52
Rochester 52
Ankara 50
Boardman 50
Menlo Park 50
Lisbon 49
Jacksonville 48
San Francisco 48
Manchester 46
Washington 46
Baltimore 45
Brisbane 45
Dallas 45
Moscow 45
Kunming 44
Lima 44
Aachen 43
Totale 21.619
Nome #
Clinical diagnosis and management of small fiber neuropathy: an update on best practice 4.779
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH) : a randomised, double-blind, placebo-controlled, phase 3 trial 3.955
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 3.399
Small fibre neuropathy : expanding the clinical pain universe 2.520
European federation of neurological societies/peripheral nerve society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. report of a joint task force of the european fe-deration of neurological societies and the peripheral nerve society 1.902
Pain in amyotrophic lateral sclerosis 1.262
Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review): Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation 891
Intraepidermal nerve fiber density and its application in sarcoidosis 499
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 498
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 492
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 457
Impact of environmental factors and physical activity on disability and quality of life in CIDP 440
Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies 434
Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients 391
Side and time variability of intraepidermal nerve fiber density 373
No efficacy of transcranial direct current stimulation on chronic migraine with medication overuse : a double blind, randomised clinical trial 357
Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy 344
Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database 320
Computational pipeline to probe NaV1.7 gain-of-function variants in neuropathic painful syndromes 312
Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments 279
Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation 274
Congenital insensitivity to pain : a novel mutation affecting a U12-type intron causes multiple aberrant splicing of SCN9A 272
Electroacupuncture Is Not Effective in Chronic Painful Neuropathies 265
Neuroprotective effects of a ligand of translocator protein-18kDa (Ro5-4864) in experimental diabetic neuropathy 240
Does CMT1A homozygosity cause more severe disease with root hypertrophy and higher CSF proteins? 234
Peripheral and central nervous system correlates in fibromyalgia 229
Erythropoietin in amyotrophic lateral sclerosis : a pilot, randomized, double-blind, placebo-controlled study of safety and tolerability 211
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 211
Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies 211
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 203
Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia 191
Altered peripheral myelination in mice lacking GABAB receptors 187
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database 187
The small fiber neuropathy NaV1.7 I228M mutation: impaired neurite integrity via bioenergetic and mitotoxic mechanisms, and protection by dexpramipexole 185
NEK1 variants confer susceptibility to amyotrophic lateral sclerosis 183
Facial onset sensory and motor neuronopathy : new cases, cognitive changes, and pathophysiology 183
Modifying the Medical Research Council grading system through Rasch analyses 182
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients 181
Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15 178
Diagnostic criteria for small fibre neuropathy in clinical practice and research 175
Altered peripheral myelination in GABA-B1-receptor knockout mice 174
Sex-dimorphic effects of dehydroepiandrosterone in diabetic neuropathy 174
Two independent mouse lines carrying the Nav1.7-I228M gain-of-function variant display DRG neuron hyperexcitability but a minimal pain phenotype 169
Neuroactive steroids and peripheral neuropathy 166
Network topology of NaV1.7 mutations in sodium channel-related painful disorders 163
Greater corneal nerve loss at the inferior whorl is related to the presence of diabetic neuropathy and painful diabetic neuropathy 162
Cortical thinning trajectories across disease stages and cognitive impairment in amyotrophic lateral sclerosis 162
Changes in peripheral myelination of GABA(B1) receptor knock-out mice 160
Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis 156
Cognitive Syndromes and C9orf72 Mutation Are Not Related to Cerebellar Degeneration in Amyotrophic Lateral Sclerosis 154
Expression of pathogenic SCN9A mutations in the zebrafish: A model to study small fiber neuropathy 152
Laser capture microdissection for transcriptomic profiles in human skin biopsies 150
Progesterone and its derivatives as protective agents in experimental diabetic neuropathy 149
Unraveling gene expression profiles in peripheral motor nerve from Amyotrophic Lateral Sclerosis patients : insights into pathogenesis 147
Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes 146
Small Nerve Fiber Pathology in Critical Illness 142
Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy 140
Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of Na V1.7 140
Gain-of-function Nav1.8 mutations in painful neuropathy 139
Erythropoietin in amyotrophic lateral sclerosis : A multicentre, randomised, double blind, placebo controlled, phase III study 139
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 136
Cortical markers of cognitive syndromes in amyotrophic lateral sclerosis 136
Cisplatin-induced peripheral neuropathy : neuroprotection by erythropoietin without affecting tumour growth 135
Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis 135
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP : Clinical relevance of IgG isotype 134
Chronic cryptogenic sensory polyneuropathy 131
The unfolded protein response in amyotrophic later sclerosis : results of a phase 2 trial 129
LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients 126
Ascorbic acid in charcot-marie-tooth disease type 1A (CMTTRIAAL and CMT-TRAUK): A double-blind randomised trial 125
A gain-of-function sodium channel beta 2-subunit mutation in painful diabetic neuropathy 125
Case 38-2001: Paraneoplastic encephalomyelitis and sensory ganglioneuropathy 122
TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis : identification of novel mutations 122
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72 120
Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 120
Neutralization of schwann cell-secreted VEGF is protective to in vitro and in vivo experimental diabetic neuropathy 119
A novel SCN9A splicing mutation in a compound heterozygous girl with congenital insensitivity to pain, hyposmia and hypogeusia 117
SARS-COV-2 comorbidity network and outcome in hospitalized patients in Crema, Italy 116
HFE p.H63D polymorphism does not influence ALS phenotype and survival 115
Bilateral Radiation-Induced Hypoglossal Nerve Palsy Responsive to Steroid Treatment 114
Erythropoietin in Friedreich ataxia : no effect on frataxin in a randomized controlled trial 113
A painful neuropathy-associated Nav1.7 mutant leads to time-dependent degeneration of small-diameter axons associated with intracellular Ca2+ dysregulation and decrease in ATP levels 112
A Delphi consensus statement of the Neuropathic Pain Special Interest Group of the Italian Neurological Society on pharmacoresistant neuropathic pain 112
CI-PERINOMS : chemotherapy-induced peripheral neuropathy outcome measures study 107
Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study 106
Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model 105
Pain and autonomic dysfunction in patients with sarcoidosis and small fibre neuropathy 105
Erythropoietin: not just about erythropoiesis 105
Erythropoietin both protects from and reverses experimental diabetic neuropathy 105
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 104
Role of Human-Induced Pluripotent Stem Cell-Derived Spinal Cord Astrocytes in the Functional Maturation of Motor Neurons in a Multielectrode Array System 103
Amyotrophic lateral sclerosis patients' and caregivers' distress and loneliness during COVID-19 lockdown 103
Life with chronic pain during COVID-19 lockdown: the case of patients with small fibre neuropathy and chronic migraine 103
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS 102
Protein misfolding, amyotrophic lateral sclerosis and guanabenz : Protocol for a phase II RCT with futility design (ProMISe trial) 101
COL6A5 variants in familial neuropathic chronic itch 101
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 99
Epithelial expression of vanilloid and cannabinoid receptors : a potential role in burning mouth syndrome pathogenesis 98
Focus on the heterogeneity of amyotrophic lateral sclerosis 98
Evaluation of molecular inversion probe versus TruSeq® custom methods for targeted next-generation sequencing 97
Pilot Randomised Controlled Trial of Methotrexate for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (RMC Trial) 96
Totale 35.722
Categoria #
all - tutte 118.927
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.927


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.021 0 0 0 0 0 0 0 0 572 742 390 317
2020/20215.559 325 412 408 339 615 436 456 428 544 479 497 620
2021/20227.440 431 489 446 624 671 842 554 532 795 717 481 858
2022/20237.007 693 426 619 534 510 967 454 486 702 451 620 545
2023/20247.679 517 595 582 762 1.015 536 523 640 397 557 803 752
2024/20257.464 621 1.061 622 985 796 769 690 1.117 803 0 0 0
Totale 46.868